Policy statement of the world hypertension league on noninvasive blood pressure measurement devices and blood pressure measurement in the clinical or community setting.

Departments of Medicine Community Health Sciences and of Physiology and Pharmacology, WHL Blood Pressure Screening Committee, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada; ISH Eastern Europe and Middle East Regional Advisory Group, American University of Beirut Medical Center, Beirut, Lebanon; Universit e du Qu ebec a Trois-Rivi eres, Quebec, Canada; Department of Family Practice, University of British Columbia, Vancouver, BC, Canada; Cardiovascular Associates, Virginia Beach, VA; Department of Medicine, University of Calgary, Foothills Medical Centre North Tower, Calgary, AB, Canada; Department of Neurosciences, Medical University of South Carolina, Charleston, SC; Department of Cardiovascular Medicine, Faculty of Medicine and Pharmaceutic Sciences, University of Douala, Douala, Cameroon; Departments of Medicine, University of Calgary, Calgary, AB, Canada; Public Health Foundation of India, Vasant Kunj, New Delhi, India; Division of Cardiology, Department of Medicine, Schulich Heart Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada; World Hypertension League, Burnaby, BC, Canada; Conway Institute of Biomolecular Research, University College Dublin, Dublin, Ireland; Hypertension Center, STRIDE Hellas-7, Third University Department of Medicine, Sotiria Hospital, Athens, Greece; Nursing College of Ribeirao Preto of University of São Paulo, São Paulo, Brazil; and Beijing Hypertension League Institute, Beijing, China